ASTELLAS PHARMA UNSP.ADR (YPHA) — Financial Flexibility Index
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Financial Flexibility Index of 0.14x as of March 2025. Free cash flow of €251.84 Billion (operating CF €194.51 Billion minus capex €57.33 Billion) represents 0% of total liabilities (€1.83 Trillion). Check ASTELLAS PHARMA UNSP.ADR liquidity resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ASTELLAS PHARMA UNSP.ADR Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for ASTELLAS PHARMA UNSP.ADR across 4 annual periods. See YPHA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for ASTELLAS PHARMA UNSP.ADR (2022–2025)
Year-by-year free cash flow to debt coverage for ASTELLAS PHARMA UNSP.ADR. For the full company profile including market capitalisation, see market cap of ASTELLAS PHARMA UNSP.ADR.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | €251.84 Billion | €194.51 Billion | €1.83 Trillion | ▲ +6.7% |
| 2024 | 0.13x | €254.97 Billion | €172.47 Billion | €1.97 Trillion | ▼ -70.6% |
| 2023 | 0.44x | €416.31 Billion | €327.77 Billion | €948.56 Billion | ▲ +14.6% |
| 2022 | 0.38x | €333.89 Billion | €257.44 Billion | €872.09 Billion | — |